|
Jun 10
|
Roche (RHHBY) NSCLC Drug Alecensa Gets EC Nod for Label Expansion
|
|
Jun 10
|
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
|
|
Jun 10
|
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer
|
|
Jun 7
|
Five-year data for Roche’s Evrysdi show the majority of treated children with a severe form of spinal muscular atrophy (SMA) achieved or maintained the ability to sit, stand or walk
|
|
Jun 7
|
Five-year Data for Genentech’s Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk
|
|
May 10
|
Q1 2024 Lineage Cell Therapeutics Inc Earnings Call
|
|
May 9
|
Phanes Therapeutics signs clinical supply agreement with Roche
|
|
May 8
|
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Q1 2024 Halozyme Therapeutics Inc Earnings Call
|
|
Apr 12
|
Roche scores FDA breakthrough status for Alzheimer’s blood test
|
|
Apr 12
|
Roche, Adaptimmune part ways on cell therapy research
|
|
Apr 11
|
Why Roche Holdings Stock Popped Today
|
|
Apr 11
|
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
|
|
Apr 11
|
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
|
|
Apr 10
|
Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study
|
|
Apr 10
|
Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Mar 26
|
Roche receives FDA approval for the first molecular test to screen for malaria in blood donors
|
|
Mar 22
|
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
|
|
Mar 21
|
Roche autoimmune disease drug disappoints in closely watched trial
|